AU2017901027A0 - Combination Therapy - Google Patents

Combination Therapy

Info

Publication number
AU2017901027A0
AU2017901027A0 AU2017901027A AU2017901027A AU2017901027A0 AU 2017901027 A0 AU2017901027 A0 AU 2017901027A0 AU 2017901027 A AU2017901027 A AU 2017901027A AU 2017901027 A AU2017901027 A AU 2017901027A AU 2017901027 A0 AU2017901027 A0 AU 2017901027A0
Authority
AU
Australia
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017901027A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QBiotics Pty Ltd
Original Assignee
QBiotics Pty Ltd
Filing date
Publication date
Application filed by QBiotics Pty Ltd filed Critical QBiotics Pty Ltd
Publication of AU2017901027A0 publication Critical patent/AU2017901027A0/en
Priority to SI201830978T priority Critical patent/SI3600281T1/en
Priority to HUE18770812A priority patent/HUE063299T2/en
Priority to JP2019552088A priority patent/JP6905075B2/en
Priority to HRP20230936TT priority patent/HRP20230936T1/en
Priority to MX2019011221A priority patent/MX2019011221A/en
Priority to FIEP18770812.8T priority patent/FI3600281T3/en
Priority to EA201992220A priority patent/EA201992220A1/en
Priority to PL18770812.8T priority patent/PL3600281T3/en
Priority to CN201880019617.4A priority patent/CN110461324A/en
Priority to PT187708128T priority patent/PT3600281T/en
Priority to MYPI2019005163A priority patent/MY197427A/en
Priority to DK18770812.8T priority patent/DK3600281T3/en
Priority to BR112019019748A priority patent/BR112019019748A2/en
Priority to US16/496,333 priority patent/US11213506B2/en
Priority to KR1020197031149A priority patent/KR102228055B1/en
Priority to PCT/AU2018/050277 priority patent/WO2018170559A1/en
Priority to IL269522A priority patent/IL269522B2/en
Priority to RS20230697A priority patent/RS64472B1/en
Priority to ES18770812T priority patent/ES2953575T3/en
Priority to NZ756754A priority patent/NZ756754A/en
Priority to UAA201910449A priority patent/UA125614C2/en
Priority to AU2018238202A priority patent/AU2018238202B2/en
Priority to CA3056685A priority patent/CA3056685C/en
Priority to SG11201907891XA priority patent/SG11201907891XA/en
Priority to EP18770812.8A priority patent/EP3600281B1/en
Priority to LTEPPCT/AU2018/050277T priority patent/LT3600281T/en
Priority to ZA2019/06001A priority patent/ZA201906001B/en
Priority to PH12019502132A priority patent/PH12019502132A1/en
Abandoned legal-status Critical Current

Links

AU2017901027A 2017-03-23 2017-03-23 Combination Therapy Abandoned AU2017901027A0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
LTEPPCT/AU2018/050277T LT3600281T (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
BR112019019748A BR112019019748A2 (en) 2017-03-23 2018-03-23 combination therapy for the treatment or prevention of tumors
PCT/AU2018/050277 WO2018170559A1 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
KR1020197031149A KR102228055B1 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumors
HRP20230936TT HRP20230936T1 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
HUE18770812A HUE063299T2 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
FIEP18770812.8T FI3600281T3 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
EA201992220A EA201992220A1 (en) 2017-03-23 2018-03-23 COMBINED THERAPY FOR TREATMENT OR PREVENTION OF TUMORS
PL18770812.8T PL3600281T3 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
CN201880019617.4A CN110461324A (en) 2017-03-23 2018-03-23 For treating or preventing the conjoint therapy of tumour
PT187708128T PT3600281T (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
MYPI2019005163A MY197427A (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
IL269522A IL269522B2 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
SI201830978T SI3600281T1 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
US16/496,333 US11213506B2 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
JP2019552088A JP6905075B2 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumors
MX2019011221A MX2019011221A (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours.
DK18770812.8T DK3600281T3 (en) 2017-03-23 2018-03-23 COMBINATION THERAPY FOR THE TREATMENT OR PREVENTION OF TUMORS
RS20230697A RS64472B1 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
ES18770812T ES2953575T3 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumors
NZ756754A NZ756754A (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
UAA201910449A UA125614C2 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumors
AU2018238202A AU2018238202B2 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
CA3056685A CA3056685C (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
SG11201907891XA SG11201907891XA (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
EP18770812.8A EP3600281B1 (en) 2017-03-23 2018-03-23 Combination therapy for the treatment or prevention of tumours
ZA2019/06001A ZA201906001B (en) 2017-03-23 2019-09-11 Combination therapy for the treatment or prevention of tumours
PH12019502132A PH12019502132A1 (en) 2017-03-23 2019-09-17 Combination therapy for the treatment or prevention of tumours

Publications (1)

Publication Number Publication Date
AU2017901027A0 true AU2017901027A0 (en) 2017-04-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP3463464A4 (en) Combination therapy
EP3732195A4 (en) Cytotoxicity-inducing therapeutic agent
EP3651772A4 (en) Combination cancer therapy
EP3768258A4 (en) Combination therapy
EP3619238A4 (en) Cytotoxicity-inducing therapeutic agent
EP3515414A4 (en) Combination therapy
EP3668507A4 (en) Combination therapy
EP3630118A4 (en) Combination therapy
EP3609520A4 (en) Targeted combination therapy
EP3419959A4 (en) Combination therapy
EP3893874A4 (en) Crenolanib combination therapy
EP3541931A4 (en) Fractal combination therapy
EP3612522A4 (en) Therapeutic compounds
EP3675891A4 (en) Combination cancer therapy
EP3624849A4 (en) Combination therapy using ascochlorin derivative
EP3655106A4 (en) Combination drug therapy
EP3717020A4 (en) Ras-targeted therapeutic
EP3801506A4 (en) Combination therapy
AU2017903033A0 (en) Bdm-i therapy
AU2017901027A0 (en) Combination Therapy
EP3426264A4 (en) Immuno-gene combination therapy
EP3730143A4 (en) Omidenepag combination
GB201706233D0 (en) Combination therapy
GB201706230D0 (en) Combination therapy
GB201706244D0 (en) Combination therapy